The alternative complement pathway and the lectin pathway are the two pathways that are important in IgA nephropathy (IgAN). So how does the dysregulation of these two pathways impact disease progression, and how might this knowledge help us optimize our approach to treating patients with IgAN? Joining Dr. Charles Turck to answer those and other key questions is nephrology specialist Dr. Carl Walther.